These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4044023)

  • 41. Nature of double-stranded DNA binding activity in seropositive rheumatoid arthritis: formation of low avidity DNA/rheumatoid factor/IgG/low density lipoprotein complexes.
    Winfield JB; Shaw M; Taylor RP; Eisenberg RA
    J Immunol; 1981 Apr; 126(4):1596-602. PubMed ID: 6162894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of dual-specific autoantibodies with dsDNA and a synthetic dimer peptide simulating the hinge region of IgG2a molecules.
    Workman CJ; Voss EW
    Mol Immunol; 2000 Oct; 37(15):931-9. PubMed ID: 11282396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating DNA-anti-DNA complexes in lupus nephritis and idiopathic nephritis.
    Williams DG; Adu D
    Proc Eur Dial Transplant Assoc; 1980; 17():629-36. PubMed ID: 6787585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical significance of antibodies to double stranded DNA (dsDNA) for systemic lupus erythematosus (SLE).
    Swaak T; Smeenk R
    Clin Rheumatol; 1987 Jun; 6 Suppl 1():56-73. PubMed ID: 3304800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Avidity of anti-native DNA antibody and glomerular immune complex localization in lupus nephritis.
    Asano Y; Nakamoto Y
    Clin Nephrol; 1978 Oct; 10(4):123-9. PubMed ID: 309813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of pressure on antigen-antibody complexes: modulation by temperature and ionic strength.
    Roy P; Roth CM; Margolies MN; Yarmush ML
    Mol Immunol; 1999 Dec; 36(17):1149-58. PubMed ID: 10698317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-dsDNA: choice of assay in relation to clinical value.
    Smeenk RJ; van den Brink HG; Brinkman K; Termaat RM; Berden JH; Swaak AJ
    Rheumatol Int; 1991; 11(3):101-7. PubMed ID: 1754810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Two cases of lupus nephritis having a high titer of anti-(histone-DNA) complex antibody without IgG anti-dsDNA antibody].
    Mizushima N; Kubota T; Nanki T; Koike R; Kohsaka H; Miyasaka N
    Rinsho Byori; 1996 Jun; 44(6):585-9. PubMed ID: 8752739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Molecular dynamics of immune complex of photoadduct-containing DNA with Fab-Anti-DNA antibody fragment].
    Akberova NI; Zhmurov AA; Nevzorova TA; Litvinov RI
    Mol Biol (Mosk); 2016; 50(3):509-19. PubMed ID: 27414790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of affinity of monoclonal antibodies against human IgG.
    Jacobsen C; Frich JR; Steensgaard J
    J Immunol Methods; 1982; 50(1):77-88. PubMed ID: 7086150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The benefit from mumps virus IgG antibody avidity testing in the population with high vaccine coverage in the context of other serological methods for laboratory diagnosis of mumps and the current epidemiological].
    Limberková R; Smíšková D; Havlíčková M; Herrmannová K; Lexová P; Marešová V
    Epidemiol Mikrobiol Imunol; 2016; 65(1):39-44. PubMed ID: 27246643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The selection of antibodies with defined desorption properties from precipitated immune complexes for use in immunoadsorption procedures.
    Folkersen J; Teisner B; Westergaard JG; Grudzinskas JG
    J Immunol Methods; 1985 Feb; 77(1):45-54. PubMed ID: 2579162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A bispecific dsDNAxmonoclonal antibody construct for clearance of anti-dsDNA IgG in systemic lupus erythematosus.
    Lindorfer MA; Schuman TA; Craig ML; Martin EN; Taylor RP
    J Immunol Methods; 2001 Feb; 248(1-2):125-38. PubMed ID: 11223074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hidden high-avidity anti-DNA antibodies occur in normal human gammaglobulin preparations.
    Saenko VA; Kabakov AE; Poverenny AM
    Immunol Lett; 1992 Sep; 34(1):1-5. PubMed ID: 1282496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The specificity of the anti-dsDNA ELISA. A closer look.
    Brinkman K; Termaat R; Van den Brink H; Berden J; Smeenk R
    J Immunol Methods; 1991 May; 139(1):91-100. PubMed ID: 2040819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of antibodies to DNA: a technical assessment.
    Smeenk R; Hylkema M
    Mol Biol Rep; 1992 Nov; 17(1):71-9. PubMed ID: 1287479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity.
    Haugbro K; Nossent JC; Winkler T; Figenschau Y; Rekvig OP
    Ann Rheum Dis; 2004 Apr; 63(4):386-94. PubMed ID: 15020332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human platelet-immune complex interaction in plasma.
    Clark WF; Tevaarwerk GJ; Reid BD
    J Lab Clin Med; 1982 Dec; 100(6):917-31. PubMed ID: 6982951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.